Biologic Safety Myths in Elderly Psoriasis Patients Under Scrutiny
Age alone is not a contraindication to biologic therapy in psoriasis, yet elderly patients remain undertreated as safety myths persist, a new Dermatology Times analysis argues.
Topic
Topic
Age alone is not a contraindication to biologic therapy in psoriasis, yet elderly patients remain undertreated as safety myths persist, a new Dermatology Times analysis argues.
Age alone should not disqualify older psoriasis patients from biologics, argues a Dermatology Times analysis dismantling persiste…